CT, MRI, and F-18 FDG PET for the detection of non-small-cell lung cancer (NSCLC)

Yi Zhang, Jinman Ni, Kongyuan Wei, Jinhui Tian, Shaobo SunMedicine 2018 · DOI

TL;DR

This paper proposes a network meta-analysis to compare the diagnostic accuracy of CT, MRI, and F-18 FDG PET for detecting early-stage non-small-cell lung cancer (NSCLC). By systematically analyzing existing studies, the authors aim to provide evidence-based recommendations for selecting the most effective diagnostic tool, addressing a critical gap in current clinical practice.

What Problem Does This Paper Address?

Non-small-cell lung cancer (NSCLC) is a leading cause of cancer-related deaths globally. While early detection is crucial for improving patient outcomes, current diagnostic strategies for identifying NSCLC at its earliest stages are not definitively ranked in terms of their effectiveness. Clinicians and patients face a challenge in choosing the optimal diagnostic test among several promising modalities: computed tomography (CT), magnetic resonance imaging (MRI), and fluorine-18 fluorodeoxyglucose positron emission tomography (F-18 FDG PET), often used in combination with CT (PET/CT). This lack of clear guidance hinders efficient and accurate early diagnosis, potentially impacting treatment success and patient survival.

Methods

The study employs a rigorous network meta-analysis approach. This involves:

  • Systematic Literature Search: Comprehensive searches of PubMed, Embase.com, and the Cochrane Central Register of Controlled Trials (CENTRAL) will be conducted to identify relevant studies published up to March 2018.
  • Inclusion Criteria: Studies will be included if they assess the diagnostic accuracy of CT, MRI, and/or F-18 FDG PET for NSCLC detection. Key requirements include the presence of at least two index tests (one of which must be CT) and sufficient data to calculate true positives (TP), false positives (FP), true negatives (TN), and false negatives (FN).
  • Quality Assessment: The risk of bias in included studies will be independently assessed using the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool.
  • Statistical Analysis: Network meta-analysis will be performed using STATA 12.0 and R 3.4.1 software. This statistical framework allows for the simultaneous comparison of multiple diagnostic tests, even when direct head-to-head comparisons are not available for all pairs.
  • Ranking: A "superiority index" will be used to rank the competing diagnostic tests, providing a more nuanced comparison than traditional metrics like the diagnostic odds ratio (DOR).

Datasets

Not discussed in the paper. The study is a meta-analysis of existing published studies, not a study that collects new data or creates new datasets.

Key Insights and Ideas

  • Addressing a Clinical Gap: The paper directly tackles the absence of clear, evidence-based guidance on selecting the best early diagnostic tool for NSCLC, a significant challenge in clinical practice.
  • Network Meta-Analysis Power: The use of network meta-analysis is a key methodological strength, enabling a comprehensive comparison of three or more diagnostic tests simultaneously, even when direct comparisons are limited. This is more powerful than traditional pairwise meta-analyses.
  • Superiority Index for Ranking: The adoption of a "superiority index" for ranking tests is noteworthy. This metric aims to provide a more robust and informative ranking by considering how well a test performs across multiple accuracy measures, rather than relying on a single metric that might be skewed by extreme values.

Key Results

This study is ongoing, and results are not yet available. The authors state that the study will be submitted to a peer-reviewed journal for publication upon completion.

Limitations and Future Work

  • Ongoing Study: The primary limitation is that the study is currently in progress, and no definitive results or conclusions can be drawn at this stage.
  • Reporting Bias: The authors explicitly state they will not investigate reporting bias due to the lack of sensitivity tests for this specific type of review.
  • Future Work: The anticipated outcome of this study is to provide "systematically suggestions to select different diagnostic measures for detecting the early NSCLC" and to establish a "priority sequence for all the 3 ways." This will serve as a valuable tool for clinical practice.

Summary updated

Abstract

PROSPEROCRD42018094542.
BibTeX
@inproceedings{zhang2018ct,
  author = {Yi Zhang and Jinman Ni and Kongyuan Wei and Jinhui Tian and Shaobo Sun},
  title = {{CT, MRI, and F-18 FDG PET for the detection of non-small-cell lung cancer (NSCLC)}},
  booktitle = {Medicine},
  year = {2018},
  doi = {10.1097/md.0000000000012387},
}
Figure